News
4h
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
7d
Best Life on MSNPeople Are Complaining About Ozempic and Wegovy’s “Life-Ruining” Side EffectDebilitating headaches are reducing their quality of life, but doctors say taking these steps can help.
Explore more
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...
The Financial Supervisory Service issued its latest consumer advisory pertaining to insurance claims for various forms of ...
Hims & Hers Health Inc. board members and executives failed to tell shareholders that its Novo Nordisk A/S Wegovy ...
The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.
The partnership helps Novo capture patients who have been using compounded versions of the medicine, while allowing WeightWatchers to reboot its drug strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results